Where does Ludwig Institute FOR Cancer Research Ltd rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Ludwig Institute FOR Cancer Research Ltd ranks #3,976 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Ludwig Institute FOR Cancer Research Ltd hold?

Ludwig Institute FOR Cancer Research Ltd holds 91 US utility patents granted between 2015 and 2025, spanning 18 technology areas.

What is Ludwig Institute FOR Cancer Research Ltd's Innovation Score?

Ludwig Institute FOR Cancer Research Ltd has an Innovation Score of 50.3 out of 100 (top 13% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Ludwig Institute FOR Cancer Research Ltd focus on?

Ludwig Institute FOR Cancer Research Ltd's top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 72 patents, ranking #263 of 7,163 assignees active in that subclass. Grants appear in 18 CPC subclasses total.

Is Ludwig Institute FOR Cancer Research Ltd's patent grant rate increasing or decreasing?

Ludwig Institute FOR Cancer Research Ltd's recent grant velocity is +10% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Ludwig Institute FOR Cancer Research Ltd's patents?

Ludwig Institute FOR Cancer Research Ltd's patents average 22.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Ludwig Institute FOR Cancer Research Ltd patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Ludwig Institute FOR Cancer Research Ltd

USPTO PatentsView assignee record - 91 granted patents across 18 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Ludwig ranks #3,976 of 49,997 tracked US assignees by granted-patent volume, with 91 patents across 18 technology areas.

#3,976
of 49,997 US assignees by volume: Top 13%
by Innovation Score (50.3/100): 22.0
avg claims per patent: +10%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3976 · Foreign Corporation #3,976 · 91 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-UP · BOOK-FULL

GRANTS-SMALL 91 grants
TOP-DECILE #3,976/49,997
PHOTO-FINISH Joyetech Europe…
CPC-FOCUS A61K · 18 areas
INNOV-PAR 50.3/100
CLAIMS-DENSE 22.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-UP +10% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Joyetech Europe Holding GmbH (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Ludwig’s 50.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 15.6 pts (31%) Velocity 6.4 pts (13%) Breadth 15.0 pts (30%) Claim depth 13.2 pts (26%)

Qualcomm Incorporated · highest

85
Federal-Mogul · near

50
Ferag · near

50
Ludwig Institute… · this assignee

50
OVD Kinegram · near

50
Thales Avionics · near

50
3D Lighting… · lowest

7

What this shows Ludwig's Innovation Score is 50.3/100 (top 13% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Ludwig?

Each dot is one of Ludwig’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Ludwig’s own 22.0 claims/patent is ABOVE the 8.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Ludwig vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Ludwig's grants concentrate

Ludwig Institute FOR Cancer Research Ltd is a focused PatentsView assignee: 18 CPC subclasses with 79.1% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2022 (13 grants) versus a trough of 3 in 2017. By volume, Ludwig sits between Joyetech Europe Holding GmbH and Patent Investment & Licensing Company.

Ludwig's three-year grant acceleration

From 2019–2021 to 2022–2024, Ludwig Institute FOR Cancer Research Ltd moved from 28 to 27 grants (0.96x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Joyetech Europe H…

91
Kofax

91
Kistler Holding

91
L&F Plastics

91
NIO Nextev

91
North China Elect…

91
National Universi…

91
Patent Investment…

91
Ludwig Institute… ◀

91

What this shows Ludwig holds 91 patents at rank #3,976, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Ludwig

By rank, the assignees closest to #3,976 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Ludwig's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Ludwig, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Ludwig ranks #263 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (50 here).

Ferag AG 50 Thales Avionics, Inc. 50 Federal-Mogul LLC 50 OVD Kinegram AG 50

Similar claim depth

Nearest assignees by average claims per patent (22.0 here).

SCA Ipla Holdings Inc. 22.1 avg JenaValve Technology, Inc. 22.1 avg iboss, Inc. 22.0 avg Kyocera AVX Components Corporation 22.1 avg

Ludwig's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

50 Top 13% higher than 87% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Ludwig Institute FOR Cancer Research Ltd patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	9	9.9%
2016	8	8.8%
2017	3	3.3%
2018	11	12.1%
2019	10	11.0%
2020	11	12.1%
2021	7	7.7%
2022	13	14.3%
2023	5	5.5%
2024	9	9.9%
2025partial year	5	5.5%

Which technologies does Ludwig Institute FOR Cancer Research Ltd patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 72

C07K - Peptides 65

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 65

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 30

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 15

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 15

Y02A - Technologies FOR Adaptation TO Climate Change 11

C12Y - Enzymes 8

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 5

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 4

C07C - Acyclic OR Carbocyclic Compounds 4

C07D - Heterocyclic Compounds 2

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 2

C40B - Combinatorial CHEMISTRY; Libraries, e.g. Chemical Libraries 1

G06T - Image Data Processing OR Generation, IN General 1

Top 15 of 18 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Ludwig Institute FOR Cancer Research Ltd's patent record in context - here's where to go next.

Ludwig Institute FOR Cancer Research Ltd's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 79.1% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #3,976 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Ludwig Institute FOR Cancer Research Ltd against Joyetech Europe Holding GmbH, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 50.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.